99 results
Page 3 of 5
8-K
EX-99.1
zdyldn rp9wo
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
EX-99.1
h08 1ldqfwaehypp3j
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
8-K
dor90h0cyrd9lntq
26 Nov 18
Other Events
9:01am
425
xw3 nfpdb
26 Nov 18
Business combination disclosure
8:59am
DEFM14A
cx9yxm3 816y2aq
6 Nov 18
Proxy related to merger
12:00am
424B3
gr4xdyi2t386rdj0x4h
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
1ekuf 4htrbrjg3d
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-99.2
0sx3b0p0zf
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
fg4hyt n86l3rbp5
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.4
qqz bvvbdlv1o
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
c923g8tn27ty
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
cbb ps5qkendd3vroa
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.4
bqfy xl9i
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
db0nltchtsh7j2ohbd1o
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
vnpsua aentk
9 Aug 18
Business combination disclosure
5:17pm